Loading content…
Affiliate-supportedIndependent editorialWe never sell medicationSee how
Midwest · Michigan
Local context for Wegovy, Ozempic, Mounjaro, and Zepbound in Detroit (630,000 residents, 4,360,000 metro). Healthy Michigan Plan (Medicaid expansion) covers T2D GLP-1s with prior auth; Henry Ford and DMC dominate the local hospital market.
Availability and prices vary by pharmacy and date. We do not maintain real-time per-pharmacy stock data. Confirm with pharmacies directly.
Wegovy
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for chronic weight management in adults and adolescents.
Wegovy in Detroit →
Ozempic
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for adults with type 2 diabetes.
Ozempic in Detroit →
Mounjaro
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for adults with type 2 diabetes.
Mounjaro in Detroit →
Zepbound
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for chronic weight management and obstructive sleep apnea.
Zepbound in Detroit →
Detroit is a midwest-region city with a population of 630,000 (4,360,000 in the broader metropolitan area). Michigan expanded Medicaid under the Affordable Care Act, which means low-income adults can typically qualify for GLP-1 coverage for type 2 diabetes if the state Medicaid program lists the drug.
Statewide, notable health systems include Michigan Medicine (U-M), Henry Ford Health, Beaumont Health.
Michigan's Medicaid program is Michigan Medicaid (Healthy Michigan Plan). Coverage rules for GLP-1 medications vary by drug and indication; see our pricing by state map and payer-coverage guides for details.
Cities of similar size with comparable healthcare markets.